STOCK TITAN

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Adicet Bio (Nasdaq: ACET) announced an inducement grant awarded on November 29, 2024. The company granted one new employee non-qualified stock options to purchase 6,000 shares at an exercise price of $1.13 per share. The shares will vest over four years, with 25% vesting after one year and the remaining 75% vesting monthly over the following three years. The grant was made under Adicet's 2022 Inducement Plan and approved by the compensation committee as a material inducement for employment in accordance with Nasdaq Rule 5635(c)(4).

Adicet Bio (Nasdaq: ACET) ha annunciato un'indennità di assunzione concessa il 29 novembre 2024. L'azienda ha concesso a un nuovo dipendente opzioni su azioni non qualificate per acquistare 6.000 azioni a un prezzo di esercizio di $1,13 per azione. Le azioni matureranno in quattro anni, con il 25% che matura dopo un anno e il restante 75% che matura mensilmente nei successivi tre anni. L'indennità è stata concessa nell'ambito del Piano di Indennità 2022 di Adicet ed è stata approvata dal comitato per le retribuzioni come un incentivo materiale per l'impiego, in conformità con la Regola 5635(c)(4) di Nasdaq.

Adicet Bio (Nasdaq: ACET) anunció una concesión de incentivo otorgada el 29 de noviembre de 2024. La compañía otorgó a un nuevo empleado opciones sobre acciones no calificadas para comprar 6,000 acciones a un precio de ejercicio de $1.13 por acción. Las acciones se adquirirán durante cuatro años, con un 25% adquiriendo derechos después de un año y el 75% restante adquiriendo derechos mensualmente durante los siguientes tres años. La concesión se realizó bajo el Plan de Incentivos 2022 de Adicet y fue aprobada por el comité de compensación como un incentivo material para el empleo de acuerdo con la Regla 5635(c)(4) de Nasdaq.

아디셋 바이오(Nasdaq: ACET)는 2024년 11월 29일에 수여된 유인 보상을 발표했습니다. 이 회사는 새롭게 채용된 직원에게 6,000주의 비과세 스톡 옵션을 부여하였으며, 행사가는 주당 $1.13입니다. 주식은 4년 동안 분할되어, 1년 후에 25%가 확정되고 나머지 75%는 이후 3년 동안 매월 확정됩니다. 이번 보상은 아디셋의 2022 유인 계획에 따라 진행되었으며, Nasdaq 규정 5635(c)(4)에 따라 고용을 위한 중요한 유인책으로 보상위원회에서 승인되었습니다.

Adicet Bio (Nasdaq: ACET) a annoncé une attribution de prime d'embauche accordée le 29 novembre 2024. L'entreprise a accordé à un nouvel employé des options sur actions non qualifiées pour acheter 6 000 actions à un prix d'exercice de 1,13 $ par action. Les actions acquerront des droits sur une période de quatre ans, avec 25 % acquérant des droits après un an et les 75 % restants acquérant des droits mensuellement au cours des trois années suivantes. L'attribution a été effectuée dans le cadre du Plan d'indemnité 2022 d'Adicet et approuvée par le comité de rémunération en tant qu'incitation matérielle à l'emploi conformément à la règle 5635(c)(4) de Nasdaq.

Adicet Bio (Nasdaq: ACET) gab am 29. November 2024 eine Anreizvergütung bekannt. Das Unternehmen gewährte einem neuen Mitarbeiter nicht qualifizierte Aktienoptionen zum Kauf von 6.000 Aktien zu einem Ausübungspreis von 1,13 $ pro Aktie. Die Aktien werden über vier Jahre hinweg aufgeteilt, wobei 25% nach einem Jahr und die verbleibenden 75% monatlich in den folgenden drei Jahren ausgebucht werden. Die Vergabe erfolgte unter dem Anreizplan 2022 von Adicet und wurde vom Vergütungsausschuss als erhebliches Anreizmittel für die Beschäftigung gemäß Nasdaq-Regel 5635(c)(4) genehmigt.

Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)-- Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on November 29, 2024.

One individual was hired by Adicet in November 2024 and granted new hire non-qualified stock options to purchase 6,000 shares of Adicet’s common stock with an exercise price of $1.13 per share, the closing price of Adicet’s common stock as reported by Nasdaq on November 29, 2024. One-fourth of the shares underlying the employee’s option will vest on the one-year anniversary of the recipient’s start date and thereafter the remaining three-fourths of the shares underlying the employee’s option will vest in thirty-six substantially equal monthly installments, such that the shares underlying the option granted to the employee will be fully vested on the fourth anniversary of the recipient’s start date, subject to the employee’s continued employment with Adicet on such vesting dates.

The above-described award was granted outside of Adicet’s stockholder-approved equity incentive plans pursuant to Adicet’s 2022 Inducement Plan (the Inducement Plan), which was adopted by the board of directors in January 2022 and subsequently amended in January 2023. The award was authorized by the compensation committee of the board of directors, which is comprised solely of independent directors, as a material inducement to the employee entering into employment with Adicet in accordance with Nasdaq Listing Rule 5635(c)(4).

About Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. For more information, please visit our website at https://www.adicetbio.com.

Adicet Bio, Inc.

Investor and Media Contacts

Investors:

Anne Bowdidge

abowdidge@adicetbio.com

Janhavi Mohite

Precision AQ

212-362-1200

janhavi.mohite@precisionaq.com

Media:

Kerry Beth Daly

kbdaly@adicetbio.com

Source: Adicet Bio, Inc.

FAQ

What was the exercise price of Adicet Bio's (ACET) inducement grant on November 29, 2024?

The exercise price of the inducement grant was $1.13 per share, which was the closing price of Adicet's common stock on Nasdaq on November 29, 2024.

How many shares were included in Adicet Bio's (ACET) November 2024 inducement grant?

The inducement grant included options to purchase 6,000 shares of Adicet's common stock.

What is the vesting schedule for Adicet Bio's (ACET) November 2024 inducement grant?

The options vest over four years, with 25% vesting after one year and the remaining 75% vesting in 36 equal monthly installments over the following three years.

Adicet Bio, Inc.

NASDAQ:ACET

ACET Rankings

ACET Latest News

ACET Stock Data

83.64M
69.64M
1.59%
76.44%
4.16%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOSTON